September 1–7, 2026 · Executive Brief
National Clinical Nurse Specialist Recognition Week 2026: Connect Recognition to Workforce Reliability
Use recognition week to make the clinical nurse specialist’s contribution visible, routable, measurable, and durable across patient care, nursing practice, and the organization.
Leadership signal
Recognition is credible when it changes how expert nursing work is designed.
National Clinical Nurse Specialist Recognition Week is observed September 1 through 7, 2026. The official theme, “Amplify: Making the Invisible Indispensable,” gives healthcare executives a practical management challenge. The work should be amplified because it is needed, but it should also become less invisible. A role that is indispensable yet structurally hidden is vulnerable to budget compression, inconsistent deployment, untracked substitution, weak succession planning, and the departure of the few people who know how the work actually gets done.
Clinical nurse specialists bring advanced nursing expertise to patients and populations, nursing practice, and organizations. That breadth is an advantage, but it can obscure contribution when work is scattered across consultations, coaching, practice review, protocol design, clinical escalation, implementation, education, quality improvement, research, and cross-service coordination. A CNS may prevent a defect, shorten the time from evidence to practice, stabilize a new standard, build a team’s capability, or connect operational groups that otherwise act separately. Each contribution can be consequential while remaining difficult to see in conventional production reports.
The leadership response should not be to force every contribution into a single dollar estimate or activity count. It should be to create a portfolio with an explicit problem, population, accountable role, authority, intervention, expected mechanism, measures, time horizon, and review point. The organization then recognizes the person and governs the work. This shifts recognition from a ceremonial moment to an operating commitment: expert nursing capability is directed to priority risks, supported with access and authority, and evaluated with evidence proportionate to the claim.
A 2025 scoping review of hospital CNS implementation found 11 relevant studies and organized implementation around framework, process, components, and evaluation. The authors concluded that role implementation is a deliberate, contextual process, not the simple addition of a job title.1 A separate 2025 policy framework applied in Portugal connected regulation, governance, education, career development, workforce planning, economic analysis, and stakeholder feedback.7 Together, these studies support a basic executive principle: a CNS role needs conditions that allow the work to function as designed.
Recognition week can therefore become a short cycle of organizational learning. Identify one high-priority clinical or workforce problem. Trace where CNS expertise enters, what authority it carries, what response it triggers, how teams receive and sustain the change, and which outcomes can reasonably be attributed. Then review what remains unsupported. If the role is indispensable, the surrounding system should not depend on informal access, heroic work, or personal memory.
Evidence signal
The literature supports value, but the strength and transferability of each signal differ.
Recent studies describe CNS and advanced nursing contributions to role implementation, workforce development, evidence-based practice, leadership, service models, and organizational value. They do not provide a single universal effect size. Designs range from scoping and systematic reviews to surveys, qualitative studies, case studies, program descriptions, and local cost reports. Leaders should use the evidence to design a credible local test, not to paste an external result into a business case as though settings, staffing, baseline performance, and attribution were identical.
Figure 1. Selected evidence signals and their limits
Implementation evidence
The hospital scoping review included 11 studies and described a multi-component implementation process.1 It supports deliberate role design, but a scoping review does not establish one best model or a causal outcome.
Local financial signal
Two CNS internship programs reported $4.3 million in savings from intern projects across four years.3 The report is operationally relevant, but it is not a controlled economic evaluation and should not be treated as a guaranteed return.
Leadership and culture
A survey of 1,047 nurses in 10 Chinese hospitals found organizational evidence-based practice culture and implementation leadership were significant predictors of EBP competence and behavior.8 Its cross-sectional design supports association, not causation.
A 2026 systematic review of advanced practice nurses in Thailand found generally favorable associations across patient, family, provider, and system outcomes, while emphasizing modest samples, heterogeneous designs, limited comparative evidence, and difficulty isolating the APN contribution from team care.16 A 2025 Ontario survey of emergency department APN models described fast-track and general emergency models among 52 respondents, with a 44.4 percent response rate.15 These findings can shape questions about deployment and model fit, but they should not be interpreted as proof that one configuration will reproduce the same result in another organization.
The safest evidence posture is explicit. Separate what is known from what is proposed. State whether an outcome is reported, associated, projected, or directly measured locally. Document the comparator and time horizon. Include workload, opportunity cost, data quality, implementation cost, and unintended effects. Recognition becomes stronger when the organization can explain both the contribution and the limits of the evidence used to describe it.
Role design
Define the work around a clinical problem, not a collection of leftover tasks.
CNS expertise is frequently deployed where care is complex, practice varies, evidence is difficult to operationalize, or a risk crosses professional and departmental boundaries. The role can include direct care, consultation, clinical coaching, implementation, surveillance, program design, evaluation, and system leadership. That range should not become an excuse for ambiguity. A portfolio needs a clear problem statement and a boundary that allows the CNS to prioritize work with the highest clinical and organizational value.
Begin with the population and the failure state. Examples include preventable deterioration, inconsistent management of a high-risk condition, avoidable device harm, delayed pain control, unreliable transition bundles, weak adoption of a clinical standard, or high variation in a specialty service. Specify where the signal appears, who can activate CNS support, what the CNS can decide directly, what requires physician, pharmacy, operations, informatics, or executive authority, and how the work returns to routine ownership after stabilization.
The mandate should distinguish expert practice from task substitution. If a CNS spends most of the week covering vacancies, completing generic education, manually reconciling data, or serving as the unbounded destination for every difficult case, the organization may be consuming advanced capability without building reliability. Some immediate service may be necessary, especially during instability, but leaders should review whether recurring work indicates a design defect, a capacity gap, or an inappropriate transfer of responsibility.
The 2024 review of CNS return on investment linked the role to the work environment, evidence-based nursing practice, turnover, quality, safety, and financial performance.2 The 2025 Portugal framework similarly showed that workforce planning and economic analysis interact with governance, regulation, education, and stakeholder agreement.7 These findings argue against evaluating a CNS only through direct billable encounters or isolated project totals. The role can create value through capability and system change, but that value still needs a defined mechanism and evidence trail.
Write the charter in operational language. Include the population, priority risks, referral or activation criteria, service promise, excluded work, decision rights, expected partners, coverage, documentation location, measurement plan, review cadence, and handback conditions. Add a capacity statement so the organization knows how much active work can be supported. When demand exceeds capacity, use an explicit prioritization method based on risk, expected benefit, urgency, readiness, and strategic alignment rather than whoever asks most loudly.
Reliability flow
Route expert nursing work from signal to sustained standard.
A reliable route begins before the CNS receives a request. The organization should define which clinical, workforce, safety, or practice signals can activate the role. Signals may arise from a bedside concern, surveillance data, a recurring exception, variation review, patient or family feedback, a new evidence recommendation, or an executive priority. Each signal needs enough context for triage and a visible response state. An informal email or hallway request cannot carry the entire control function for high-risk work.
After activation, the CNS validates the problem and determines whether direct clinical support, consultation, workflow redesign, evidence review, education, escalation, or a broader improvement project is needed. Not every signal should become a project. Some require immediate expertise and a documented handback. Others reveal recurring conditions that need an interdisciplinary response. The decision should be visible so requestors know whether work was accepted, redirected, deferred, or escalated, and why.
Figure 2. Proposed CNS reliability route
The middle of the route is where many initiatives fail. Evidence has to be translated into a workflow that fits clinical reality, and leaders have to protect the conditions required for adoption. A qualitative scoping review of 14 studies found that leadership frameworks were experienced as contextual tools. Workplace culture, structural support, mentorship, resources, and clinical realities shaped whether leaders could close the knowing-doing gap.9 A 2026 collective case study of two units with strong implementation described formal and informal nurse leaders collaboratively enacting change, relational, and task-oriented behaviors.10 The practical implication is that a CNS cannot carry adoption alone. Managers, informal leaders, educators, informatics, physicians, pharmacists, and operational teams need assigned parts of the work.
Handback is as important as activation. When a practice stabilizes, ownership should return to the team that operates it every day, supported by a standard, training, documentation, audit, escalation rule, and named review owner. The CNS may continue surveillance or periodic consultation, but the standard should not depend on permanent personal rescue. If measures worsen, exceptions rise, or context changes, the route reactivates. That feedback loop converts one-time expertise into an organizational capability.
Workforce pipeline
Build the role before vacancies become a strategic surprise.
Recognition without a pipeline can intensify a familiar contradiction: the organization celebrates expert nurses while leaving entry routes uncertain, positions inconsistently funded, and successors undeveloped. Recent CNS workforce reports describe recruitment pressure and practical responses. A 2026 “grow your own” toolkit article presents internal talent development as a response to the CNS shortage and includes implementation examples of cost avoidance and quality improvement.4 A 2024 article describes a health-system CNS internship designed to recruit nurses into CNS education while providing hands-on role experience and easing transition after graduation.5
A 2026 report on two internship programs described $4.3 million in project savings across four years.3 This is a compelling local signal, but the economic claim should remain tied to its reported settings, attribution method, project selection, and measurement period. A local internship business case should include tuition or stipend support, protected supervision, project costs, position commitments, retention assumptions, and the risk that a graduate completes preparation without a funded CNS role.
Cancer nursing provides another context. A three-year Pan-London CNS development lead pilot was designed around recruitment, retention, mentorship, leadership, structured career progression, and alignment with a national career framework. Early findings reported improved workforce sustainability and retention, while noting geography, information technology, and long-term funding challenges.6 Because the report is an early oncology program evaluation, its lessons should be adapted rather than generalized as a proven system-wide model.
A pipeline should start with service need, not only interested candidates. Forecast the clinical portfolios that require advanced nursing expertise over the next three to five years. Identify current CNS retirement and turnover risk, hard-to-recruit specialties, succession coverage, educational capacity, clinical placement capacity, qualified preceptors, and the positions that will exist at graduation. Link candidate development to transparent selection, equitable access, academic readiness, mentoring, and a defined transition-to-practice period.
Career growth matters beyond one role. A 2026 scoping review mapped 70 sources on nursing career growth and connected opportunities, organizational strategies, perceptions, and workforce outcomes such as satisfaction and intention to stay.14 The review covers nursing broadly and does not establish that a CNS pipeline alone will change retention. It does support designing visible career structures rather than relying on chance access to sponsorship.
Leaders should monitor who enters and completes the pipeline, who receives high-value developmental work, whether protected time is real, whether preceptors have capacity, and whether candidates can see a funded role ahead. A program that expands education but not positions creates frustration. A program that creates positions without transition support creates avoidable risk. A program that depends on one sponsor is not yet durable.
Implementation leadership
Protect the conditions that let expertise change practice.
Evidence translation is often described as a competency problem, but studies repeatedly point to organizational conditions. In the 10-hospital survey of 1,047 nurses, implementation leadership and evidence-based practice culture were mutually related to EBP competence and behavior.8 The cross-sectional design cannot establish the direction of cause, yet it reinforces the need to develop leaders and culture together. Training individuals while leaving workload, access to evidence, data, decision rights, and local support unchanged is unlikely to produce a durable practice.
A qualitative study of 12 advanced practice nurses found variation in how EBP was realized, gaps in leadership competence, and inadequate supporting resources.11 A clinical academic research academy in one large NHS trust was developed to address time, skills, authority, and organizational support barriers to nurse research engagement.12 An Air Force nursing fellowship reported six fellows, $40,000 in grants, five evidence-based practice projects, two research studies, six clinical inquiry initiatives, and 20 knowledge products.13 These are program examples, not controlled comparative evidence, but they show the infrastructure that can sit behind visible outputs.
For a CNS portfolio, protected time must be an operational agreement rather than a nominal allocation. Define which responsibilities stop or transfer when the CNS leads implementation. Provide access to analysts, informatics, educators, librarians or evidence support, improvement expertise, and clinical governance. Create a rapid route for decisions that cross departments. Give managers and informal frontline leaders explicit responsibilities in adoption, because they shape whether the new practice survives routine workload and competing demands.
Leadership education should be designed with realistic claims. A 2026 scoping review of 22 publications on leadership education for person-centered health and social care found that work-based, longitudinal approaches were common and that reported outcomes were largely self-reported. The review did not formally appraise methodological quality.17 Local leadership development should therefore pair learning participation and confidence with observable practice behaviors, team experience, adoption, and operational outcomes. Completion is a delivery measure, not proof of impact.
Value and attribution
Show the mechanism, not just the result.
CNS value can appear as improved outcomes, reduced harm, better experience, greater practice consistency, stronger staff capability, avoided utilization, shorter cycle time, better retention, or cost avoidance. The measurement challenge is that these outcomes are influenced by teams, baseline conditions, case mix, concurrent initiatives, and external changes. A credible value narrative begins with the causal path. Describe what the CNS did, which behavior or process should change, which outcome should respond, how long that response could reasonably take, and what other factors may explain the result.
Use a portfolio ledger. For each initiative, record the baseline period, population, intervention, implementation cost, data source, numerator, denominator, comparator, balancing measures, start date, maturity point, and review owner. If estimating avoided cost, state the unit cost, source, assumptions, realized versus projected status, and whether savings were cash-releasing, capacity-releasing, or theoretical. Do not add unlike dollars from overlapping projects. Do not attribute a whole service-line trend to one role without a design that supports the claim.
The return-on-investment article describes the CNS as relevant to work environment, turnover, evidence-based practice, quality, safety, and financial stability.2 The internship report offers a concrete savings signal.3 These sources support measurement ambition, but local leaders still need transparent attribution. A strong report may conclude that a contribution is plausible and directionally favorable while the exact independent effect remains uncertain.
Include capability value as well as project value. When the CNS develops nurses’ assessment, decision-making, evidence appraisal, or implementation skill, the result may extend beyond one intervention. Measure reach, observed competency, adoption, maintenance, and the amount of expert rescue still required. If the team can sustain the practice, respond appropriately to exceptions, and teach new staff, the organization has converted individual expertise into a more durable capability.
Balance the portfolio. Review patient and workforce outcomes alongside cost. A project that lowers supply expense but increases nurse workload, delays care, or shifts burden to patients is not a complete success. A practice improvement that raises short-term reporting because surveillance becomes more accurate should not be misclassified as deterioration without investigation. Staff and patient narratives can explain mechanisms and burden, but they should complement rather than replace valid denominators.
Equity belongs in the value model. Examine who was eligible, who received the intervention, who completed it, and who benefited. Stratification requires valid data, privacy protection, and careful handling of small numbers. An observed difference is a signal for investigation, not proof of cause. Pair data with people who understand the workflow and with those who experience it.
Figure 3. Qualitative fishbone for invisible or unstable CNS value
Operating system
Give the role a governed route, not a larger inbox.
A durable CNS operating system connects strategic priorities, clinical authority, portfolio intake, direct and indirect practice, implementation support, measurement, workforce development, and executive review. It does not require a large new bureaucracy. It requires named owners and visible states. The minimum governance group should include an executive sponsor, CNS practice leader or clinical authority, operational partners, nursing managers, data support, finance, workforce development, and patient or family partnership appropriate to the portfolio.
Portfolio intake should show the problem, population, source, urgency, current owner, requested CNS contribution, expected mechanism, decision required, and due state. Triage distinguishes direct clinical support, consultation, rapid evidence response, time-limited improvement, strategic program work, education, and work that belongs elsewhere. A shared queue prevents high-risk requests from disappearing across email and helps leaders see demand that exceeds capacity.
The operating system also needs practice partnership. The Ontario emergency department survey found multiple APN models of care and called for workforce planning aligned to priority patient needs.15 The Thailand review emphasized that clearer career structures, defined scopes, supportive leadership, education, and EBP capacity are context-dependent enablers.16 These studies involve advanced practice configurations beyond a single U.S. CNS model. They support a question, not a prescription: does the local deployment match the population, service problem, authority, and supporting conditions?
Figure 4. Proposed CNS workforce reliability operating system
Daily control
Review urgent clinical signals, unassigned requests, missing information, overdue responses, capacity conflicts, and issues requiring immediate clinical authority.
Monthly portfolio
Review active initiatives, stage, workload, adoption, outcomes, balancing measures, attribution limits, handback readiness, and resource constraints.
Quarterly workforce
Review vacancies, succession exposure, candidate pipeline, preceptor capacity, retention, portfolio coverage, equity, and the funded positions required ahead.
Measurement
Use a scorecard that keeps reach, adoption, outcomes, capability, and cost distinct.
One composite “CNS impact” score would hide more than it reveals. Measures need stage-specific denominators and an interpretation rule. Portfolio acceptance is measured against eligible requests. Practice adoption is measured among the units or clinicians expected to use the practice. Patient outcomes are measured among the defined population. Capability is measured among people who received the development intervention and had a valid observation opportunity. Financial results require stated assumptions and implementation costs.
Figure 5. Structured CNS portfolio scorecard
| Measure | Numerator | Denominator | Source and owner | Cadence | Interpretation limit |
|---|---|---|---|---|---|
| Eligible demand accepted | Eligible requests accepted into the CNS portfolio | Requests meeting the approved activation criteria | Portfolio queue; CNS practice leader | Monthly | Acceptance does not indicate completion or benefit |
| First response completed | Accepted requests with a documented initial response | Accepted requests for which a response was due | Portfolio queue; current CNS owner | Weekly | The locally set response window is an operating standard, not a universal clinical deadline |
| Implementation reach | Eligible units, clinicians, or patients exposed to the intervention | Units, clinicians, or patients intended to receive it | Implementation log; project owner | Monthly | Exposure does not prove correct use |
| Practice adoption | Eligible observations meeting the defined practice standard | Valid observations among those expected to use the practice | Audit or validated EHR data; operational manager | Monthly | Documentation may not equal actual practice |
| Patient or population outcome | People meeting the defined outcome criterion | Eligible population during the same measurement period | Validated clinical data; data steward and clinical authority | Monthly or quarterly | Concurrent changes and case mix may affect the result |
| Balancing outcome | Occurrences of the specified burden, delay, substitution, or harm | Population with a valid opportunity for the balancing event | Clinical, workforce, or experience data; operational owner | Monthly | Low reporting can reflect weak detection |
| Observed capability | Participants meeting the defined observable competency | Participants trained and validly observed | Competency assessment; nursing professional development lead | Quarterly | Training completion and self-confidence are not sufficient measures |
| Practice maintained | Adopting units still meeting the standard at the review point | Units that initially adopted and reached the review point | Follow-up audit; manager and CNS | Quarterly | A stable percentage can conceal unequal performance or surveillance gaps |
| Portfolio handed back | Initiatives with routine owner, standard, data, escalation, and review in place | Initiatives judged ready for handback | Portfolio review; governance group | Monthly | Closure does not eliminate the need for surveillance |
| Cost or capacity result | Validated realized cost reduction, avoidance, or capacity released | Approved baseline or comparator units | Finance-validated analysis; finance partner | Quarterly | State assumptions, implementation cost, attribution, and whether value is cash-releasing |
| Workforce stability | CNS roles filled, retained, or covered according to the defined metric | Funded CNS roles or at-risk portfolios | Human resources and workforce plan; nursing workforce leader | Quarterly | Small numbers and labor-market changes limit interpretation |
| Pipeline progression | Candidates reaching the defined education or transition milestone | Candidates eligible for that milestone | Pipeline tracker; academic and workforce leads | Quarterly | Progress does not guarantee a funded role or retention |
| Experience and equity | The stage-specific numerator selected above | Its matching stage-specific denominator | Validated linked data and direct feedback; experience and equity leads | Quarterly | Observed differences require investigation and do not establish cause |
Targets should follow a validated baseline, evidence review, capacity assessment, and governance decision. An external program’s cost savings, response rate, or fellowship output is not a ready-made local target. Report missingness and denominator changes. If a measure is new, run a validation period before using it for performance judgment. Use case review to understand why the numbers move, then change the process only after the likely cause is verified.
Executive agenda
A 90-day test can connect recognition to durable infrastructure.
Days 1 to 30
Define and listen
- Name the executive sponsor, clinical authority, CNS portfolio owner, data steward, finance partner, workforce lead, and experience partners.
- Select one priority population, clinical problem, and CNS portfolio.
- Map activation, triage, decision rights, implementation support, handback, and exceptions.
- Validate baseline data and document attribution limits.
- Review current workforce coverage, successor risk, and capacity.
Days 31 to 60
Build and rehearse
- Create the minimum portfolio queue and operating definitions.
- Approve the role charter, decision rights, service promise, and escalation route.
- Assign formal and informal implementation leaders.
- Confirm protected time, data access, education, informatics, and finance support.
- Begin a bounded pilot and review exceptions weekly.
Days 61 to 90
Learn and decide
- Review reach, adoption, patient and workforce outcomes, balancing measures, cost, capability, and experience.
- Investigate variation with records, observation, and direct listening.
- Correct verified role, workflow, authority, or capacity defects.
- Confirm handback, maintenance, succession, and reactivation conditions.
- Adapt, expand, pause, or stop through governance review.
Figure 6. Proposed 90-day implementation timeline
The day-90 report should distinguish delivery, adoption, outcome, and attribution. Include the tested population, role boundary, data quality, workload, patient and workforce outcomes, cost assumptions, balancing measures, experience, equity review, pipeline exposure, and unresolved risks. Recognition is connected to reliability when leaders can see what the CNS changed, what the team now owns, what remains uncertain, and what support is required next.
Leadership close
Make expert nursing work visible enough to govern and supported enough to last.
National Clinical Nurse Specialist Recognition Week is a moment to thank clinicians whose influence often extends beyond a single encounter or department. The stronger executive response is to remove the organizational invisibility around the work. Define the problem and population. Give the role authority and access. Route demand. Protect implementation conditions. Measure distinct stages with valid denominators. Develop successors. Review value honestly, including limits and balancing effects.
The 2026 theme asks organizations to make the invisible indispensable. In practice, indispensability should not mean fragility or dependence on heroics. It should mean that expert nursing contribution is deliberately embedded in clinical standards, workforce capability, governance, and learning. The person is recognized, the contribution is traceable, and the system can maintain the improvement.
Peer-reviewed references
Research used in this executive brief
- Bachiller-Barquín A, Martín-Martín J, Vázquez-Calatayud M. Implementing the Clinical Nurse Specialist Role in Hospital Settings: A Scoping Review. Clinical Nurse Specialist. 2025;39(2):65-81. doi:10.1097/NUR.0000000000000884
- DiLibero J, Mohr LD, Burton-Williams KM, et al. The Clinical Nurse Specialist: Maximizing Return on Investment. Nursing Administration Quarterly. 2024;48(4):286-296. doi:10.1097/NAQ.0000000000000652
- Cummins M, Wilk C, Plata A. Investing in a Clinical Nurse Specialist Internship: A Valuable Strategy to Drive Organizational Impact. Nurse Leader. 2026;24(1). doi:10.1016/j.mnl.2025.102612
- Mohr LD, Powers J, Boss K, et al. Growing Your Own: A Clinical Nurse Specialist Development Toolkit for Healthcare Leaders. Journal of Nursing Administration. 2026;56(2):97-103. doi:10.1097/NNA.0000000000001687
- Boss K, Wilk C, Gorsuch P, Motter T. Development of a Clinical Nurse Specialist Internship to Promote Evidence-Based Practice and Improve Outcomes. Nurse Leader. 2024;22(5):577-581. doi:10.1016/j.mnl.2023.12.012
- Dean L, Kumaralingam N, Harris M, et al. Strengthening the cancer clinical nurse specialist workforce: insights from a pilot CNS development project. British Journal of Nursing. 2026;35(10):S4-S10. doi:10.12968/bjon.2025.0138
- Amorim-Lopes M, Cruz-Gomes S, Doldi E, Almada-Lobo B. From policy to practice: Rolling out the clinical nurse specialist role in Portugal. Health Policy. 2025;155:105308. doi:10.1016/j.healthpol.2025.105308
- Hu S, Liu S, Li X, et al. Organizational evidence-based practice culture, implementation leadership, and nurses: A bidirectional mediation model. International Nursing Review. 2025;72(2):1-11. doi:10.1111/inr.13054
- Marks L, Biles J, Kornhaber R, Fontenot J. Nursing Leadership in Practice: A Qualitative Scoping Review of Framework Implementation Experiences in Public Healthcare Systems. Journal of Nursing Management. 2026;2026:1-19. doi:10.1155/jonm/8807131
- Castiglione SA, Lavoie-Tremblay M, Kilpatrick K, Gifford W, Semenic SE. How Formal and Informal Nurse Leaders Enact Shared Implementation Leadership in a Hospital Setting. Journal of Advanced Nursing. 2026;82(8):7987-8005. doi:10.1111/jan.70374
- Ylimäki S, Oikarinen A, Kääriäinen M, et al. Advanced practice nurses' experiences of evidence-based practice: A qualitative study. Nordic Journal of Nursing Research. 2022;42(4):227-235. doi:10.1177/20571585221097658
- Ryan S, Finney A, Lamph G, Dobel-Ober D, Darrant J, Lambley-Burke R. Increasing research engagement among nurses: the development of a clinical academic research academy in a large health and social care NHS trust. Nurse Researcher. 2026;34(2):18-25. doi:10.7748/nr.2025.e2001
- Migliore L, Jumpp S, Fox A, et al. Clinical Inquiry in Nursing Readiness Fellowship: Increasing Air Force Nurse Corps Evidence-Based Practice Leadership Infrastructure. Military Medicine. 2024;189(Supplement):14-23. doi:10.1093/milmed/usad083
- Osorio-Leyton T, Wensley CJ, Li N, Ferrer L, Jacobs S. Career Growth in nursing: A scoping review of nurses’ opportunities, organisational strategies, perceptions, and workforce outcomes. Investigación & Educación en Enfermería. 2026;44(2):134-183. doi:10.17533/udea.iee.v44n2e10
- Horvath S, Visekruna S, Kilpatrick K, McCallum M, Carter N. Ontario Emergency Department Models of Care With Nurse Practitioners and Clinical Nurse Specialists. Nursing Leadership. 2025;38(2):69-87. doi:10.12927/cjnl.2025.27719
- Whaikid P, Piaseu N. Roles and Outcomes of Advanced Practice Nurses in Thailand: A Systematic Review. Healthcare. 2026;14(15):2300. doi:10.3390/healthcare14152300
- Lood Q, Lalloo EC, Bergholtz J, Barenfeld E. Leadership education to support person-centred health and social care: A scoping review of empirical literature. PLoS ONE. 2026;21(6):1-21. doi:10.1371/journal.pone.0350991
Executive-use note: This article provides evidence-informed management guidance, not clinical, legal, labor, credentialing, or financial advice. Organizations should adapt role scope, staffing, privileges, measurement, privacy, labor practices, and implementation to applicable law, regulation, accreditation, professional standards, contracts, local governance, and patient needs.